A piece of the melanoma puzzle

Journal of the National Cancer Institute

Volumn 97, Issue 20, 2005, Pages 1486-1487

  Goldstein, Alisa M ^a   Tucker, Margaret A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR;

BREAST CANCER; CANCER RISK; CARCINOGENESIS; CONFIDENCE INTERVAL; DISEASE CARRIER; EDITORIAL; ENVIRONMENTAL FACTOR; FAMILY HISTORY; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HUMAN; INCIDENCE; MELANOMA; PATIENT COUNSELING; PENETRANCE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; AGE; AUSTRALIA; CANADA; EUROPE; GENETIC PREDISPOSITION; GENETICS; MORTALITY; MUTATION; NOTE; SKIN TUMOR; SURVIVAL RATE; TUMOR SUPPRESSOR GENE; UNITED STATES;

AGE FACTORS; BRITISH COLUMBIA; EUROPE; GENES, P16; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; INCIDENCE; LOGISTIC MODELS; MELANOMA; NEW SOUTH WALES; ONTARIO; PENETRANCE; RISK ASSESSMENT; SKIN NEOPLASMS; SURVIVAL RATE; UNITED STATES;

EID: 27144531061     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dji359     Document Type: Editorial

References (17)

1. Kefford R, Newton Bishop J, Tucker M, Bressac-de Paillerets B, Bianchi-Scarra G, Bergman W, et al., on behalf of the Melanoma Genetics Consortium. Genetic testing for melanoma. Lancet Oncol 2002;3:653-4.
2. Hayward NK. Genetics of melanoma predisposition. Oncogene 2003;22: 3053-62.
3. Goldstein AM, Tucker MA. Familial melanoma and its management. In: Eeles RA, Easton DF, Ponder BAJ, Eng C, editors. Genetic predisposition to cancer, 2nd ed. London (U.K.): Arnold; 2004. p. 352-9.
4. Begg CB, Orlow I, Hummer AJ, Armstrong BK, Kricker A, Marrett LD, et al. Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. J Natl Cancer Inst 2005;97:1507-15.
5. Ford D, Bliss JM, Swerdlow AJ, Armstrong BK, Franceschi S, Green A, et al. Risk of cutaneous melanoma associated with a family history of the disease. The International Melanoma Analysis Group (IMAGE). Int J Cancer 1995;62:377-81.
6. Chatterjee N, Wacholder S. A marginal likelihood approach for estimating penetrance from kin-cohort designs. Biometrics 2001;57:245-52.
7. Wacholder S, Hartge P, Struewing JP, Pee D, McAdams M, Brody L, et al. The kin-cohort study for estimating penetrance. Am J Epidemiol 1998;148:623-30.
8. Begg CB. On the use of familial aggregation in population-based case probands for calculating penetrance. J Natl Cancer Inst 2002;94:1221-6.
9. Bishop DT, Demenais F, Goldstein AM, Bergman W, Newton Bishop J, Bressac-de Paillerets B, et al. Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst 2002;94:894-903.
10. Box NF, Duffy DL, Chen W, Stark M, Martin NG, Sturm RA, Hayward NK. MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. Am J Hum Genet 2001;69:765-73.
11. van der Velden PA, Sandkuijl LA, Bergman W, Pavel S, van Mourik L, Frants RR, et al. Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma. Am J Hum Genet 2001;69:774-9.
12. Chaudru V, Chompret A, Miniere A, Laud K, Avril M-F, Bressac-de Paillerets B, et al. Joint effects of MC1R gene, naevus phenotypes and sun-related covariates on CDKN2A penetrance in French melanoma-prone families. Proceedings of the First International Melanoma Research Congress, 2003 June 21-14; Philadelphia, (PA).
13. Chaudru V, Chompret A, Bressac-de Paillerets B, Spatz A, Avril MF, Demenais F. Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families. J Natl Cancer Inst 2004;96:785-95.
14. Goldstein AM, Falk RT, Fraser MC, Dracopoli NC, Sikorsky RS, Clark WH, et al. Sun-related risk factors for melanoma-prone families with CDKN2A mutations. J Natl Cancer Inst 1998;90:709-11.
15. Goldstein AM, Landi MT, Tsang S, Fraser MC, Munroe DJ, Tucker MA. Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations. Cancer Epidemiol Biomarkers Prev 2005;14:2208-12.
16. Kefford RF, Newton Bishop JA, Bergman W, Tucker MA, on behalf of the Melanoma Genetics Consortium. Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma. J Clin Oncol 1999; 17:3245-51.
17. National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. Surveillance, Epidemiology and End Results Program. SEER*Stat Database: Populations - Total U.S. (1969-2002), 2005. Available at: http://www.seer.cancer.gov.